Analysis of eIF4E and 4EBP1 mRNAs in head and neck cancer

Laryngoscope

Volumn 121, Issue 10, 2011, Pages 2136-2141

  Sunavala Dossabhoy, Gulshan ^a   Palaniyandi, Senthilnathan ^a   Clark, Cheryl ^a   Nathan, Cherie Ann O ^a   Abreo, Fleurette W ^a   Caldito, Gloria ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

4EBP1; biomarker; eIF4E; head and neck cancer; prognosis

Indexed keywords

BINDING PROTEIN; INITIATION FACTOR 4E; INITIATION FACTOR 4E BINDING PROTEIN 1; MESSENGER RNA;

ADULT; ARTICLE; CANCER GROWTH; CANCER RECURRENCE; CELL PROLIFERATION; CLINICAL ARTICLE; CLINICAL DECISION MAKING; CONTACT EXAMINATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE FREE SURVIVAL; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION; GENE OVEREXPRESSION; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; HUMAN TISSUE; KAPLAN MEIER METHOD; MALE; PATHOLOGY; PATIENT CARE; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANK SUM TEST; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; TISSUE SECTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; AGED; BIOPSY, NEEDLE; CARCINOMA; CHI-SQUARE DISTRIBUTION; COHORT STUDIES; DISEASE PROGRESSION; EUKARYOTIC INITIATION FACTOR-4E; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASMS, SQUAMOUS CELL; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK ASSESSMENT; RNA, MESSENGER; RNA-BINDING PROTEINS; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; TISSUE CULTURE TECHNIQUES; TUMOR MARKERS, BIOLOGICAL;

EID: 80053201933     PISSN: 0023852X     EISSN: 15314995     Source Type: Journal    
DOI: 10.1002/lary.22144     Document Type: Article

References (15)

1. Graff J, De Benedetti A,. eIF-4E expression and its role in malignancies and metastases. Oncogene 2004; 23: 3189-3199. (Pubitemid 38638830)
2. Nathan CO, Franklin S, Abreo FW, Nassar R, De Benedetti A, Glass J,. Analysis of surgical margins with the molecular marker eIF4E: a prognostic factor in patients with head and neck cancer. J Clin Oncol 1999; 17: 2909-2914. (Pubitemid 29415252)
3. Haydon MS, Googe JD, Sorrells DS, Ghali GE, Li BD,. Progression of eIF4E gene amplification and overexpression in benign and malignant tumors of the head and neck. Cancer 2000; 88: 2803-2810. (Pubitemid 30417942)
4. Graff JR, Konicek BW, Vincent TM, et al. Therapeutic suppression of translation initiation factor eIF4E expression reduced tumor growth without toxicity. J Clin Invest 2007; 117: 2638-2648. (Pubitemid 47494364)
5. Welsh GI, Miyamoto S, Price NT, Safer B, Proud CG,. T-cell activation leads to rapid stimulation of translation initiation factor eIF4E and inactivation of glycogen synthase kinase-3. J Biol Chem 1996; 271: 11410-11413. (Pubitemid 26155980)
6. Franklin S, Pho T, Abreo FW, Nassar R, De Benedetti A, Stucker FJ, Nathan CO,. Detection of the proto-oncogene eIF4E in larynx and hypopharynx cancers. Arch Otolaryngol Head Neck Surg 1999; 125: 177-182. (Pubitemid 29085266)
7. Topisirovic I, Siddiqui N, Orolicki S, Skrabanek LA, Tremblay M, Hoang T, Borden KL,. Stability of eukaryotic translation initiation factor 4E mRNA is regulated by HuR, and this activity is dysregulated in cancer. Mol Cell Biol 2009; 29: 1152-1162.
8. Anthony B, Carter P, De Benedetti A,. Overexpression of the proto-oncogene/translation initiation factor 4E in breast carcinoma cell lines. Int J Cancer 1996; 65: 858-863. (Pubitemid 26127757)
9. Rousseau D, Gingras A-C, Pause A, Sonenberg N,. The eIF4E binding proteins 1 and 2 are negative regulators of cell growth. Oncogene 1996; 13: 2415-2420. (Pubitemid 27026024)
10. Kim YY, Von Weymarn L, Larsson O, et al. Eukaryotic initiation factor 4E binding protein family of proteins: sentinels at a translational control checkpoint in lung tumor defense. Cancer Res 2009; 69: 8455-8462.
11. Martin MF, Perez MI, Redondo C, Alvarez MI, Salinas M, Fando JL,. 4E binding protein 1 expression is inversely correlated to the progression of gastrointestinal cancers. Int J Biochem Cell Biol 2000; 32: 633-642. (Pubitemid 30227360)
12. Armengol G, Rojo F, Castellvi J, et al. 4E-binding protein 1: a key molecular "funnel factor" in human cancer with clinical implications. Cancer Res 2007; 67: 7551-7555. (Pubitemid 47281345)
13. Furic L, Rong L, Larsson O, et al. eIF4E phosphorylation promotes tumorigenesis and is associated with prostate cancer progression. Proc Natl Acad Sci USA 2010; 107: 14134-14139.
14. Konicek BW, Stephens JR, McNulty AM, et al. Therapeutic inhibition of MAP kinase interacting kinase blocks eukaryotic translation initiation factor 4E phosphorylation and suppresses experimental lung metastasis. Cancer Res 2011; 71: 1849-1857.
15. Fisher PM,. Cap in hand: targeting eIF4E. Cell Cycle 2009; 8: 2535-2541.